Key predictive variables identified included alanine aminotransferase, gammaglutamyl transpeptidase, triglyceride glucose–waist circumference, metabolic score for insulin resistance, and HbA1c, which are strongly associated with metabolic dysfunctions integral to NAFLD progression. The gene discussed is GGTLC1; the disease is metabolic dysfunction-associated steatotic liver disease.